Panzara Michael A.

See Remarks | Chief Medical Officer | Franchise Lead, Neurology +1 more

1 company

Panzara Michael A. is a See Remarks at Wave Life Sciences Ltd.. Recent SEC Form 4 filings include 0 buys and 11 sells.

Estimated insider holdings value: $790K based on current market prices.

Holdings by Company

WVEMay 5, 2022

Current Shares109.1K

Value$789.9K

Net Activity-71,797

Bought: 0Sold: 71.8K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 5, 2022	WVE Wave Life Sciences Ltd.	See Remarks	Sell	16,714	$1.72	$28,748.08	-13.3%	+41.1%	+128.0%
Feb 16, 2022	WVE Wave Life Sciences Ltd.	See Remarks	Sell	10,603	$2.31	$24,492.93	-12.3%	-56.2%	+60.0%
Feb 16, 2021	WVE Wave Life Sciences Ltd.	See Remarks	Sell	2,929	$10.57	$30,959.53	-3.3%	-	-
Feb 18, 2020	WVE Wave Life Sciences Ltd.	Chief Medical Officer	Sell	2,981	$7.85	$23,400.85	-7.0%	-	-
Jul 5, 2019	WVE Wave Life Sciences Ltd.	Chief Medical Officer	Sell	3,058	$26.94	$82,368.14	-3.5%	-	-
Mar 11, 2019	WVE Wave Life Sciences Ltd.	Franchise Lead, Neurology	Sell	7,000	$48.00	$336,000.00	-13.4%	-	-
Feb 19, 2019	WVE Wave Life Sciences Ltd.	Franchise Lead, Neurology	Sell	1,837	$36.84	$67,673.98	-4.7%	-	-
Feb 16, 2018	WVE Wave Life Sciences Ltd.	Franchise Lead, Neurology	Sell	511	$52.10	$26,623.10	-1.3%	-	-
Feb 15, 2018	WVE Wave Life Sciences Ltd.	Franchise Lead, Neurology	Sale+OE	18,750	$50.00	$937,500.00	-32.1%	-	-
Jul 12, 2017	WVE Wave Life Sciences Ltd.	Franchise Lead, Neurology	Sell	7,414	$16.67	$123,619.55	-32.6%	-	-